In Tfh PTCL, TET2 and DNMT3A mutations are detected in neoplastic T cells and also in various cell subsets, such as CD34-derived colonies, CD34+ cells [16] and B cells isolated from AITL biopsies. This evidence concerns the gene TET2 and angioimmunoblastic T-cell lymphoma.